Navigation Links
RxAlly Adds Accomplished Clinical Services Expert And Pharmacist, Rebecca Chater, To The Company's Leadership Team
Date:12/4/2012

LEESBURG, Va., Dec. 4, 2012 /PRNewswire/ -- RxAlly, a first-of-its-kind alliance of more than 22,000 pharmacies nationwide, announced today that Rebecca Chater, RPh, MPH, FAPhA, has joined the company's leadership team as Vice President of Health Outcomes.  In this role, Ms. Chater will be responsible for providing leadership and clinical management of RxAlly solutions, as well as integrating business development with clinical staff and operations.

Ms. Chater brings to RxAlly more than 20 years of experience leading innovative clinical services programs and launching community pharmacy initiatives proven to enhance patient health outcomes and lower health care costs, including the highly regarded Asheville Project.

"Rebecca's impressive credentials and extensive track record of success speaks to both her tremendous expertise and her genuine passion for enhancing the value of community-based, patient-focused, quality pharmacy care.  We are very fortunate to have her on board," said Bruce Roberts, CEO of RxAlly. "Her role will be critical in helping RxAlly develop and implement on a national scale industry-leading clinical service programs that support RxAlly's member pharmacies in providing the highest quality pharmacy care available."

Most recently, Rebecca Chater served as an Executive Vice President at Kerr Health, a North Carolina-based local chain of 77 community pharmacies which spearheaded development and implementation of patient-centric pharmacy care, health screening and disease management services in local pharmacies across the state, including urban and rural locations.  While at Kerr, Rebecca provided clinical leadership in the Specialty, Long Term Care and Care Management divisions, including developing and implementing an integrated model of clinical programs that optimized patient outcomes, ensured clinical efficiencies and controlled costs.  She also collaborated with other executive leaders to develop and implement an organizational strategic plan, identify gaps and design solutions for performance improvement, and provide guidance and oversight for two key Medical Home projects enacted by the North Carolina General Assembly. 

"RxAlly's goal is to empower community pharmacies to provide personalized pharmacist care to improve health outcomes and lower health care costs, so it's a perfect fit with what I have been focusing on professionally for a long time," Chater said.  "I am particularly excited at the prospect of working alongside RxAlly's highly-capable leadership team and with the many forward-thinking and dedicated pharmacists at the local level to help advance pharmacy care on a national scale."

Ms. Chater's other prior professional roles include serving as President of KDI Health Solutions, LLC, and playing an instrumental role in the Asheville Project, which serves as a model for delivering health solutions and patient-centric care through community pharmacy.  Ms. Chater is an Elected Member and Past-President of the North Carolina Board of Pharmacy and has served as Visiting Clinical Assistant Professor in the Department of Pharmacotherapy at the University Of North Carolina Eshelman School of Pharmacy.  She earned both her Master's Degree in Public Health and her Bachelor of Science in Pharmacy at the University of North Carolina at Chapel Hill.

RxAlly is a performance network of aligned pharmacies, united to help patients achieve better health through personalized pharmacist care while reducing costs.  The company was developed to provide a new solution to the critical issues of providing additional access to care and ensuring effective health care spending at a time when prescription medicine misuse is associated with $290 billion in annual costs.  For media inquiries, please contact: 5W Public Relations.

About RxAlly
With more than 22,000 member pharmacies nationwide, RxAlly has brought together the largest national network of pharmacies to improve health and lower costs. The RxAlly Performance Network of community pharmacies aims to improve health through personalized pharmacist care, clinical research and evidence-based clinical practices, and an interoperable technology platform. By advancing the role of pharmacists, RxAlly is facilitating new solutions as it leads an innovative approach to health care that aligns the interests of patients, pharmacists and payers. For more information, please visit us at: www.RxAlly.com, on Facebook or Twitter.

Contact:

Susan Weingram / 5W Public Relations


O: 212-584-4271 / E: sweingram@5wpr.com


'/>"/>
SOURCE RxAlly
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. RxAlly Member Pharmacies Invited To Become The Preferred Network For Smart Insurance Company Holdings, Inc.
2. RxAlly Strengthens Leadership Team With New Chief Information Officer Mike Groh
3. RxAlly Adds Nationally Recognized Health Care Policy Professional Wayne Oliver To The Companys Leadership Team
4. RxAlly Announces Addition Of Experienced Corporate Counsel Tom OGrady To The Companys Leadership Team
5. RxAlly Opens Its Doors In Leesburg, Virginia
6. RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies
7. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
8. Elseviers Clinical Pharmacology Now Accessible Through Elsevier Infobutton
9. ClinicalKey Key Innovator Award to Recognize the Innovative Use of Health Information and Technology to Save and Improve Lives
10. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
11. Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... "The World Market for Companion Diagnostic Tests" report to ... World Market for Companion Diagnostics The World ... diagnostic and personalized medicine diagnostics. Market analysis in the report ... Diagnostics Test Market (In Vitro Diagnostic Kits) by Region (N. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... today its affiliation with Tennessee Counseling Association. This new relationship allows ... the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified ... be personalized through a fitness app. The fitness app plans to fix the two major ... only offer a one size fits all type program , They don’t eliminate ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
Breaking Medicine News(10 mins):